Literature DB >> 4312923

Bordetella pertussis serotypes in the United States.

G Eldering, J Holwerda, A Davis, J Baker.   

Abstract

To determine the Bordetella pertussis serotypes currently causing whooping cough in the United States, recently isolated cultures from different geographic areas were studied. Specific adsorbed antisera were prepared in our laboratory and used in both tube and slide agglutination tests. Among the 177 cultures isolated during 1966 and 1967 in seven states and one Canadian province, the predominant serotype was 1.3 (or 1.3.6), represented by 85% of the cultures. Fifteen cultures were serotype 1.2.3.4.6. The 376 cultures isolated in the Grand Rapids area during the last 30 years showed a changing pattern from serotype 1.2.3 during the early years to the currently prevailing 1.3 (or 1.3.6). During the 2-year study period, seven cultures of B. parapertussis were isolated in Michigan, and seven were received from other states. One culture of B. bronchiseptica, recovered from a child in Boston, was sent to us.

Entities:  

Mesh:

Year:  1969        PMID: 4312923      PMCID: PMC378047          DOI: 10.1128/am.18.4.618-621.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  11 in total

1.  TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH.

Authors:  N W PRESTON
Journal:  Br Med J       Date:  1963-09-21

2.  THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES.

Authors:  N CHALVARDJIAN
Journal:  Can Med Assoc J       Date:  1965-05-22       Impact factor: 8.262

3.  EFFECTIVENESS OF PERTUSSIS VACCINES.

Authors:  N W PRESTON
Journal:  Br Med J       Date:  1965-07-03

4.  Type-specific immunity against intracerebral pertussis infection in mice.

Authors:  N W PRESTON; P EVANS
Journal:  Nature       Date:  1963-02-02       Impact factor: 49.962

5.  Serological study of Bordetella pertussis and related species.

Authors:  G ELDERING; C HORNBECK; J BAKER
Journal:  J Bacteriol       Date:  1957-08       Impact factor: 3.490

6.  The failure to show correlation between type-specificity and protection in experimental pertussis in mice.

Authors:  E K ANDERSEN; M W BENTZON
Journal:  Acta Pathol Microbiol Scand       Date:  1958

7.  [Serology of Bordetella pertussis. I. Distribution of serotypes].

Authors:  S Mebel
Journal:  Zentralbl Bakteriol Orig       Date:  1968-05

8.  The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.

Authors:  L B Holt; V Spasojevíc
Journal:  J Med Microbiol       Date:  1968-08       Impact factor: 2.472

9.  Bordetella pertussis culture having only species factor 1.

Authors:  G Eldering; J Holwerda; J Baker
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

10.  Mouse-protective properties of Bordetella pertussis serotypes in passive tests.

Authors:  G Eldering; J Holwerda; J Baker
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

View more
  11 in total

1.  Bordetella pertussis serotypes in Canada.

Authors:  S Toma; H Lo; M Magus
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

2.  Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

Authors:  S C M van Amersfoorth; L M Schouls; H G J van der Heide; A Advani; H O Hallander; K Bondeson; C H W von König; M Riffelmann; C Vahrenholz; N Guiso; V Caro; E Njamkepo; Q He; J Mertsola; F R Mooi
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period.

Authors:  C Bronne-Shanbury; D Miller; A F Standfast
Journal:  J Hyg (Lond)       Date:  1976-04

4.  Pertussis outbreak in Austin and Travis County, Texas, 1975.

Authors:  L H Field; C D Parker
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

5.  Prevalent serotypes of Bordetella pertussis in non-vaccinated communities.

Authors:  N W Preston
Journal:  J Hyg (Lond)       Date:  1976-08

Review 6.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

7.  Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.

Authors:  M J Brennan; Z M Li; J L Cowell; M E Bisher; A C Steven; P Novotny; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.

Authors:  J L Cowell; J M Zhang; A Urisu; A Suzuki; A C Steven; T Liu; T Y Liu; C R Manclark
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

9.  Purification and characterization of fimbriae isolated from Bordetella pertussis.

Authors:  J M Zhang; J L Cowell; A C Steven; P H Carter; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

Review 10.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.